Cargando…
Overexpressed pseudogene MT1L associated with tumor immune infiltrates and indicates a worse prognosis in BLCA
BACKGROUND: BLCA is a common cancer worldwide, and it is both aggressive and fatal. Immunotherapy (ICT) has achieved an excellent curative effect in BLCA; however, only some BLCA patients can benefit from ICT. MT1L is a pseudogene, and a previous study suggested that MT1L can be used as an indicator...
Autores principales: | Ding, Yanpeng, Liu, Nuomin, Chen, Mengge, Xu, Yulian, Fang, Sha, Xiang, Wenbin, Hua, Xinying, Chen, Gaili, Zhong, Yahua, Yu, Haijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063461/ https://www.ncbi.nlm.nih.gov/pubmed/33888142 http://dx.doi.org/10.1186/s12957-021-02231-4 |
Ejemplares similares
-
MT1X is an oncogene and indicates prognosis in ccRCC
por: Ding, Yanpeng, et al.
Publicado: (2022) -
Pathogenic and Diagnostic Potential of BLCA-1 and BLCA-4 Nuclear Proteins in Urothelial Cell Carcinoma of Human Bladder
por: Santoni, Matteo, et al.
Publicado: (2012) -
Development of a prognostic model to predict BLCA based on anoikis-related gene signature: preliminary findings
por: Zhu, Shusheng, et al.
Publicado: (2023) -
The Relationship of Pyroptosis-Related Genes, Patient Outcomes, and Tumor-Infiltrating Cells in Bladder Urothelial Carcinoma (BLCA)
por: Xie, Ruiyan, et al.
Publicado: (2022) -
A Multiomics Profiling Based on Online Database Revealed Prognostic Biomarkers of BLCA
por: Li, Hanwen, et al.
Publicado: (2022)